Characterization of Monocyte-derived IFNα-generated Dendritic Cells
暂无分享,去创建一个
R. Fenk | S. Schinner | M. Schott | A. Raffel | T. Baehring | C. Papewalis | B. Jacobs | M. Wuttke | Jochen Seissler | C. Stüßgen
[1] M. Schott. Immunesurveillance by dendritic cells: potential implication for immunotherapy of endocrine cancers. , 2006, Endocrine-related cancer.
[2] W. Scherbaum,et al. Dendritic cells as potential adjuvant for immunotherapy in adrenocortical carcinoma , 2006, Clinical endocrinology.
[3] J. Sprent,et al. Type I interferons act directly on CD8 T cells to allow clonal expansion and memory formation in response to viral infection , 2005, The Journal of experimental medicine.
[4] H. Ueno,et al. Immune and Clinical Outcomes in Patients with Stage IV Melanoma Vaccinated with Peptide-Pulsed Dendritic Cells Derived From CD34+ Progenitors and Activated with Type I Interferon , 2005, Journal of immunotherapy.
[5] J. Seissler,et al. Dendritic cell vaccination: new hope for the treatment of metastasized endocrine malignancies , 2003, Trends in Endocrinology & Metabolism.
[6] T. Di Pucchio,et al. Expression of CCR-7, MIP-3beta, and Th-1 chemokines in type I IFN-induced monocyte-derived dendritic cells: importance for the rapid acquisition of potent migratory and functional activities. , 2001, Blood.
[7] T. Di Pucchio,et al. Type I Interferon as a Powerful Adjuvant for Monocyte-Derived Dendritic Cell Development and Activity in Vitro and in Hu-Pbl-Scid Mice , 2000, The Journal of experimental medicine.
[8] K. Schooley,et al. Human Dendritic Cells Mediate Cellular Apoptosis via Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand (Trail) , 1999, The Journal of experimental medicine.
[9] N. Kadowaki,et al. The nature of the principal type 1 interferon-producing cells in human blood. , 1999, Science.
[10] C. Maliszewski,et al. Monocyte-mediated Tumoricidal Activity via the Tumor Necrosis Factor–related Cytokine, TRAIL , 1999, The Journal of experimental medicine.
[11] N. Kadowaki,et al. Reciprocal control of T helper cell and dendritic cell differentiation. , 1999, Science.
[12] P. Marrack,et al. Type I Interferons Keep Activated T Cells Alive , 1999, The Journal of experimental medicine.
[13] J. Sprent,et al. Type I Interferon-mediated Stimulation of T Cells by CpG DNA , 1998, Journal of Experimental Medicine.
[14] S Pestka,et al. Biological properties of recombinant alpha-interferons: 40th anniversary of the discovery of interferons. , 1998, Cancer research.
[15] J U Gutterman,et al. Cytokine therapeutics: lessons from interferon alpha. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[16] G. Trinchieri,et al. Anti-viral activity induced by culturing lymphocytes with tumor-derived or virus-transformed cells. Enhancement of human natural killer cell activity by interferon and antagonistic inhibition of susceptibility of target cells to lysis , 1978, The Journal of experimental medicine.